Study 410 Enrollment Update: Multicenter, Open-Label, Phase IV Study of Perampanel as Monotherapy or First Adjunctive Therapy in Patients with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) (P3.5-019)

Abstract

Study 410 Enrollment Update: Multicenter, Open-Label, Phase IV Study of Perampanel as Monotherapy or First Adjunctive Therapy in Patients with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) (P3.5-019)